Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3048 |
|
Actual shortage: | 226 (7%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2799 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
HEARTBURN CONTROL | 20MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-02-19 | 2021-04-26 | 134413 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-02-26 | 2021-03-08 | 134814 |
APO-QUINAPRIL | 20MG | TABLET | Actual shortage | 2021-03-15 | 2021-12-03 | 135692 |
APO-METHYLPHENIDATE | 20MG | TABLET | Resolved | 2021-04-05 | 2021-05-17 | 136799 |
APO-VARDENAFIL | 20MG | TABLET | Resolved | 2021-04-05 | 2021-10-25 | 136817 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-04-09 | 2021-05-17 | 137244 |
APO-PAROXETINE | 20MG | TABLET | Resolved | 2021-04-16 | 2021-04-26 | 137592 |
APO-ESCITALOPRAM | 20MG | TABLET | Resolved | 2021-04-30 | 2021-05-17 | 138343 |
APO-BACLOFEN | 20MG | TABLET | Resolved | 2021-05-14 | 2021-08-03 | 139403 |
APO-FLUOXETINE | 20MG | CAPSULE | Resolved | 2021-07-05 | 2021-09-27 | 141848 |
APO-PRAVASTATIN | 20MG | TABLET | Resolved | 2021-07-09 | 2021-10-05 | 142280 |
APO-FOSINOPRIL | 20MG | TABLET | Resolved | 2021-07-16 | 2021-08-03 | 142677 |
APO-TADALAFIL | 20MG | TABLET | Resolved | 2021-07-16 | 2021-08-16 | 142690 |
APO-SIMVASTATIN | 20MG | TABLET | Resolved | 2021-07-23 | 2022-03-01 | 142985 |
APO-PRAVASTATIN | 20MG | TABLET | Resolved | 2021-08-16 | 2021-10-05 | 144189 |
APO-ENALAPRIL | 20MG | TABLET | Resolved | 2021-08-27 | 2022-07-11 | 144672 |
APO-CETIRIZINE | 20MG | TABLET | Resolved | 2021-10-29 | 2021-12-06 | 148496 |
APO-OLANZAPINE ODT | 20MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-10-29 | 2021-11-26 | 148503 |
APO-TADALAFIL | 20MG | TABLET | Resolved | 2021-11-12 | 2021-11-29 | 149170 |
APO-PANTOPRAZOLE | 20MG | TABLET (DELAYED-RELEASE) | Resolved | 2021-12-03 | 2022-02-14 | 150435 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
COATED DAILY LOW DOSE ASA 81 MG | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2019-01-03 | 2019-01-04 | 71083 |
APO-FUROSEMIDE | 80MG | TABLET | Discontinued | 2017-03-30 | 2018-02-05 | 4719 |
APO-SOTALOL | 80MG | TABLET | Discontinued | 2017-03-31 | 2018-12-07 | 4936 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40817 |
APO-TELMISARTAN | 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40820 |
APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
APO-GLICLAZIDE | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60512 |
APO-DICLO SR | 75MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-03-31 | 2017-03-31 | 4915 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-DIPYRIDAMOLE | 75MG | TABLET | Discontinued | 2019-12-20 | 2019-12-21 | 101880 |
APO-FENTANYL MATRIX | 75MCG | PATCH | Discontinued | 2018-09-07 | 2018-09-15 | 60497 |
APO-CIPROFLOX | 750MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60388 |
APO-MELOXICAM | 7.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60612 |
APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |